Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Med. 2013 Nov;19(11):1469-72. doi: 10.1038/nm.3352. Epub 2013 Oct 27.

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.

Author information

  • 11] Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA. [2].

Abstract

We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein). Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic. Treatment of cells expressing NTRK1 fusions with inhibitors of TRKA kinase activity inhibited autophosphorylation of TRKA and cell growth. Tumor samples from 3 of 91 patients with lung cancer (3.3%) without known oncogenic alterations assayed by next-generation sequencing or fluorescence in situ hybridization demonstrated evidence of NTRK1 gene fusions.

PMID:
24162815
[PubMed - indexed for MEDLINE]
PMCID:
PMC3823836
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk